Summary

A nebulizer is a medication delivery tool that allows medicine to be sprayed into the lungs. These devices create a fine mist by forcing pressurized air through the liquid through a mouthpiece or mask. These devices are intended to treat respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis.
The nebulizer market growth is driven by increase in prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Nebulizers are commonly used to administer medication and manage these conditions. For instance, in 2022, according to National Library of Medicine, it was reported that, COPD affects 1 in 10 of the adult global population and is one of the three commonest causes of death worldwide. It is also a major cause of global inequalities in health and is more prevalent where such inequalities are more extreme.

Moreover, as the global population continues to age, there is a growing demand for respiratory care devices, including nebulizers, since older individuals are more susceptible to respiratory conditions. In addition, increase in levels of air pollution in many urban areas have led to a higher incidence of respiratory disorders and advances in nebulizer technology have improved their efficiency, ease of use, and portability, making them more appealing to both patients and healthcare providers.

In addition, a growing trend towards home healthcare and self-management of chronic illnesses has increased the use of nebulizers, as they can be used at home without the need for frequent hospital visits. Along with that Nebulizers are commonly used for children with respiratory issues, as they are effective and less intimidating than other delivery methods. The pediatric nebulizer market is a significant contributor to overall growth.
On the other hand, nebulizer devices, especially newer and more advanced models, can be expensive. This cost can be a barrier to access for some patients, particularly in regions with limited healthcare resources or for individuals with financial constraints. Thus, this factor is anticipated to restrain the growth of the market.

The nebulizer market is segmented into type, product, application, portability, end user, and region. Based on type the market is classified into jet nebulizer, ultrasonic nebulizer, and mesh nebulizer. Based on product, the market is segmented into equipment and accessories. Based on application the market is segmented into COPD, asthma and others. Based on potability, the market is bifurcated into tabletop and portable. Based on end user the market is divided into hospitals, clinics and homecare setting.

Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Major key players that operate in the global nebulizer market are OMRON Healthcare, Inc, Koninklijke Philips N.V., DeVilbiss Healthcare LLC., GF Health Products, Inc., Trudell Medical International Inc., Allied Healthcare Products, Inc., Teleflex Incorporated, Vyaire Medical, Inc., PARI Respiratory Equipment Inc., and Rossmax International Ltd. Key players operating in the market have adopted product approval, product launch, acquisition, and agreement as their key strategies to expand their nebulizer market share.

Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nebulizer market analysis from 2022 to 2032 to identify the prevailing nebulizer market opportunities.
●The market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the nebulizer market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global nebulizer market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● Product Benchmarking / Product specification and applications
● Upcoming/New Entrant by Regions
● New Product Development/ Product Matrix of Key Players
● Patient/epidemiology data at country, region, global level
● Additional company profiles with specific to client's interest
● Additional country or region analysis- market size and forecast
● Expanded list for Company Profiles
● Historic market data
● SWOT Analysis
Key Market Segments
By Type
● Jet nebulizer
● Ultrasonic nebulizer
● Mesh nebulizer
By Product
● Equipment
● Accessories
By Application
● COPD
● Asthma
● Others
By Portability
● Tabletop
● Portable
By End User
● Hospital
● Clinics
● Homecare setting
By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ France
○ UK
○ Italy
○ Spain
○ Rest of Europe
● Asia-Pacific
○ Japan
○ China
○ India
○ Australia
○ South Korea
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ South Africa
○ Rest of LAMEA
● Key Market Players
○ DeVilbiss Healthcare LLC.
○ Trudell Medical International Inc.
○ Allied Healthcare Products, Inc.
○ Vyaire Medical, Inc.
○ PARI Respiratory Equipment Inc.
○ Rossmax International Ltd
○ OMRON Healthcare, Inc
○ GF Health Products, Inc.
○ Teleflex Incorporated
○ Koninklijke Philips N.V.

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of respiratory diseases.
3.4.1.2. Increase in number of geriatric population.
3.4.2. Restraints
3.4.2.1. Lack of awareness regarding use of nebulizer at homecare setting
3.4.3. Opportunities
3.4.3.1. Rise in adoption of key strategies by market players
CHAPTER 4: NEBULIZER MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Jet nebulizer
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Ultrasonic nebulizer
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Mesh nebulizer
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: NEBULIZER MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Equipment
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Accessories
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: NEBULIZER MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. COPD
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Asthma
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: NEBULIZER MARKET, BY PORTABILITY
7.1. Overview
7.1.1. Market size and forecast
7.2. Tabletop
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Portable
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
CHAPTER 8: NEBULIZER MARKET, BY END USER
8.1. Overview
8.1.1. Market size and forecast
8.2. Hospital
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by region
8.2.3. Market share analysis by country
8.3. Clinics
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by region
8.3.3. Market share analysis by country
8.4. Homecare setting
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by region
8.4.3. Market share analysis by country
CHAPTER 9: NEBULIZER MARKET, BY REGION
9.1. Overview
9.1.1. Market size and forecast By Region
9.2. North America
9.2.1. Key market trends, growth factors and opportunities
9.2.2. Market size and forecast, by Type
9.2.3. Market size and forecast, by Product
9.2.4. Market size and forecast, by Application
9.2.5. Market size and forecast, by Portability
9.2.6. Market size and forecast, by End User
9.2.7. Market size and forecast, by country
9.2.7.1. U.S.
9.2.7.1.1. Market size and forecast, by Type
9.2.7.1.2. Market size and forecast, by Product
9.2.7.1.3. Market size and forecast, by Application
9.2.7.1.4. Market size and forecast, by Portability
9.2.7.1.5. Market size and forecast, by End User
9.2.7.2. Canada
9.2.7.2.1. Market size and forecast, by Type
9.2.7.2.2. Market size and forecast, by Product
9.2.7.2.3. Market size and forecast, by Application
9.2.7.2.4. Market size and forecast, by Portability
9.2.7.2.5. Market size and forecast, by End User
9.2.7.3. Mexico
9.2.7.3.1. Market size and forecast, by Type
9.2.7.3.2. Market size and forecast, by Product
9.2.7.3.3. Market size and forecast, by Application
9.2.7.3.4. Market size and forecast, by Portability
9.2.7.3.5. Market size and forecast, by End User
9.3. Europe
9.3.1. Key market trends, growth factors and opportunities
9.3.2. Market size and forecast, by Type
9.3.3. Market size and forecast, by Product
9.3.4. Market size and forecast, by Application
9.3.5. Market size and forecast, by Portability
9.3.6. Market size and forecast, by End User
9.3.7. Market size and forecast, by country
9.3.7.1. Germany
9.3.7.1.1. Market size and forecast, by Type
9.3.7.1.2. Market size and forecast, by Product
9.3.7.1.3. Market size and forecast, by Application
9.3.7.1.4. Market size and forecast, by Portability
9.3.7.1.5. Market size and forecast, by End User
9.3.7.2. France
9.3.7.2.1. Market size and forecast, by Type
9.3.7.2.2. Market size and forecast, by Product
9.3.7.2.3. Market size and forecast, by Application
9.3.7.2.4. Market size and forecast, by Portability
9.3.7.2.5. Market size and forecast, by End User
9.3.7.3. UK
9.3.7.3.1. Market size and forecast, by Type
9.3.7.3.2. Market size and forecast, by Product
9.3.7.3.3. Market size and forecast, by Application
9.3.7.3.4. Market size and forecast, by Portability
9.3.7.3.5. Market size and forecast, by End User
9.3.7.4. Italy
9.3.7.4.1. Market size and forecast, by Type
9.3.7.4.2. Market size and forecast, by Product
9.3.7.4.3. Market size and forecast, by Application
9.3.7.4.4. Market size and forecast, by Portability
9.3.7.4.5. Market size and forecast, by End User
9.3.7.5. Spain
9.3.7.5.1. Market size and forecast, by Type
9.3.7.5.2. Market size and forecast, by Product
9.3.7.5.3. Market size and forecast, by Application
9.3.7.5.4. Market size and forecast, by Portability
9.3.7.5.5. Market size and forecast, by End User
9.3.7.6. Rest of Europe
9.3.7.6.1. Market size and forecast, by Type
9.3.7.6.2. Market size and forecast, by Product
9.3.7.6.3. Market size and forecast, by Application
9.3.7.6.4. Market size and forecast, by Portability
9.3.7.6.5. Market size and forecast, by End User
9.4. Asia-Pacific
9.4.1. Key market trends, growth factors and opportunities
9.4.2. Market size and forecast, by Type
9.4.3. Market size and forecast, by Product
9.4.4. Market size and forecast, by Application
9.4.5. Market size and forecast, by Portability
9.4.6. Market size and forecast, by End User
9.4.7. Market size and forecast, by country
9.4.7.1. Japan
9.4.7.1.1. Market size and forecast, by Type
9.4.7.1.2. Market size and forecast, by Product
9.4.7.1.3. Market size and forecast, by Application
9.4.7.1.4. Market size and forecast, by Portability
9.4.7.1.5. Market size and forecast, by End User
9.4.7.2. China
9.4.7.2.1. Market size and forecast, by Type
9.4.7.2.2. Market size and forecast, by Product
9.4.7.2.3. Market size and forecast, by Application
9.4.7.2.4. Market size and forecast, by Portability
9.4.7.2.5. Market size and forecast, by End User
9.4.7.3. India
9.4.7.3.1. Market size and forecast, by Type
9.4.7.3.2. Market size and forecast, by Product
9.4.7.3.3. Market size and forecast, by Application
9.4.7.3.4. Market size and forecast, by Portability
9.4.7.3.5. Market size and forecast, by End User
9.4.7.4. Australia
9.4.7.4.1. Market size and forecast, by Type
9.4.7.4.2. Market size and forecast, by Product
9.4.7.4.3. Market size and forecast, by Application
9.4.7.4.4. Market size and forecast, by Portability
9.4.7.4.5. Market size and forecast, by End User
9.4.7.5. South Korea
9.4.7.5.1. Market size and forecast, by Type
9.4.7.5.2. Market size and forecast, by Product
9.4.7.5.3. Market size and forecast, by Application
9.4.7.5.4. Market size and forecast, by Portability
9.4.7.5.5. Market size and forecast, by End User
9.4.7.6. Rest of Asia-Pacific
9.4.7.6.1. Market size and forecast, by Type
9.4.7.6.2. Market size and forecast, by Product
9.4.7.6.3. Market size and forecast, by Application
9.4.7.6.4. Market size and forecast, by Portability
9.4.7.6.5. Market size and forecast, by End User
9.5. LAMEA
9.5.1. Key market trends, growth factors and opportunities
9.5.2. Market size and forecast, by Type
9.5.3. Market size and forecast, by Product
9.5.4. Market size and forecast, by Application
9.5.5. Market size and forecast, by Portability
9.5.6. Market size and forecast, by End User
9.5.7. Market size and forecast, by country
9.5.7.1. Brazil
9.5.7.1.1. Market size and forecast, by Type
9.5.7.1.2. Market size and forecast, by Product
9.5.7.1.3. Market size and forecast, by Application
9.5.7.1.4. Market size and forecast, by Portability
9.5.7.1.5. Market size and forecast, by End User
9.5.7.2. Saudi Arabia
9.5.7.2.1. Market size and forecast, by Type
9.5.7.2.2. Market size and forecast, by Product
9.5.7.2.3. Market size and forecast, by Application
9.5.7.2.4. Market size and forecast, by Portability
9.5.7.2.5. Market size and forecast, by End User
9.5.7.3. South Africa
9.5.7.3.1. Market size and forecast, by Type
9.5.7.3.2. Market size and forecast, by Product
9.5.7.3.3. Market size and forecast, by Application
9.5.7.3.4. Market size and forecast, by Portability
9.5.7.3.5. Market size and forecast, by End User
9.5.7.4. Rest of LAMEA
9.5.7.4.1. Market size and forecast, by Type
9.5.7.4.2. Market size and forecast, by Product
9.5.7.4.3. Market size and forecast, by Application
9.5.7.4.4. Market size and forecast, by Portability
9.5.7.4.5. Market size and forecast, by End User
CHAPTER 10: COMPETITIVE LANDSCAPE
10.1. Introduction
10.2. Top winning strategies
10.3. Product mapping of top 10 player
10.4. Competitive dashboard
10.5. Competitive heatmap
10.6. Top player positioning, 2022
CHAPTER 11: COMPANY PROFILES
11.1. OMRON Healthcare, Inc
11.1.1. Company overview
11.1.2. Key executives
11.1.3. Company snapshot
11.1.4. Operating business segments
11.1.5. Product portfolio
11.1.6. Business performance
11.2. Koninklijke Philips N.V.
11.2.1. Company overview
11.2.2. Key executives
11.2.3. Company snapshot
11.2.4. Operating business segments
11.2.5. Product portfolio
11.2.6. Business performance
11.3. PARI Respiratory Equipment Inc.
11.3.1. Company overview
11.3.2. Key executives
11.3.3. Company snapshot
11.3.4. Operating business segments
11.3.5. Product portfolio
11.3.6. Key strategic moves and developments
11.4. DeVilbiss Healthcare LLC.
11.4.1. Company overview
11.4.2. Key executives
11.4.3. Company snapshot
11.4.4. Operating business segments
11.4.5. Product portfolio
11.5. GF Health Products, Inc.
11.5.1. Company overview
11.5.2. Key executives
11.5.3. Company snapshot
11.5.4. Operating business segments
11.5.5. Product portfolio
11.6. Trudell Medical International Inc.
11.6.1. Company overview
11.6.2. Key executives
11.6.3. Company snapshot
11.6.4. Operating business segments
11.6.5. Product portfolio
11.7. Allied Healthcare Products, Inc.
11.7.1. Company overview
11.7.2. Key executives
11.7.3. Company snapshot
11.7.4. Operating business segments
11.7.5. Product portfolio
11.7.6. Business performance
11.8. Teleflex Incorporated
11.8.1. Company overview
11.8.2. Key executives
11.8.3. Company snapshot
11.8.4. Operating business segments
11.8.5. Product portfolio
11.8.6. Business performance
11.9. Rossmax International Ltd
11.9.1. Company overview
11.9.2. Key executives
11.9.3. Company snapshot
11.9.4. Operating business segments
11.9.5. Product portfolio
11.9.6. Key strategic moves and developments
11.10. Vyaire Medical, Inc.
11.10.1. Company overview
11.10.2. Key executives
11.10.3. Company snapshot
11.10.4. Operating business segments
11.10.5. Product portfolio